Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-08-27

Clinical Trial Update: Trial Evaluating the Safety and Efficacy Of MR-Linac-Guided Radiotherapy as Salvage Treatment After External Beam Radiotherapy Recurrence (TUMORNATOR II) [NA]

View source ↗

Summary

This update covers the TUMORNATOR II trial, evaluating MR-Linac-guided radiotherapy as salvage treatment for intraprostatic prostate cancer after external beam …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: NYU Langone Health | Conditions: Intraprostatic Prostate Cancer | NA | Status: RECRUITING